Lates News

According to AI Express, Guoyuan Securities released a research report on April 1, giving Autobio Diagnostics a "buy" rating. The main reasons for the rating include: 1) the company's 2025 annual report shows overall steady growth in performance; 2) steady progress in global customer expansion, with continued strengthening of the ability to export automotive electronics; 3) continuous advancement of the layout of humanoid robots, with gradual emergence of industrial synergies. (Daily Economic News)